Dr. S. Vincent Rajkumar
MBBS, Residency Internal Medicine, Fellowship Hematology & Medical Oncology, ABIM Certified
Professor of Medicine & Consultant Hematologist
corporate_fareMayo Clinic, Rochester, Minnesota
S. Vincent Rajkumar
MBBS, Residency Internal Medicine, Fellowship Hematology & Medical Oncology, ABIM Certified
Dr. S. Vincent Rajkumar is a Professor of Medicine and consultant in the Division of Hematology and Division of Hematopathology at Mayo Clinic, Rochester, Minnesota. He holds the Edward W. and Betty Knight Scripps Professor of Medicine chair and chairs the Myeloma Amyloidosis Dysproteinemia Group at Mayo Clinic. He is internationally recognised as one of the foremost authorities on multiple myeloma, amyloidosis, and related plasma cell disorders.
Dr. Rajkumar trained at Christian Medical College, Vellore, before completing his residency in Internal Medicine at the University of North Dakota and his fellowship in Hematology and Medical Oncology at Mayo Graduate School of Medicine. Over his career at Mayo Clinic, he has served as principal investigator on multiple pivotal clinical trials in myeloma, including studies that contributed to the US regulatory approval of thalidomide for multiple myeloma. His research spans biomarker development, novel therapies, epidemiology, racial disparities in plasma cell disorders, and clinical trial design. He has published more than 800 peer-reviewed articles, reviews, book chapters, and editorials, and serves as Editor-in-Chief of Blood Cancer Journal. He co-chairs the International Myeloma Working Group and chairs the Myeloma Committee of the ECOG-ACRIN Cancer Research Group.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Dr. Rajkumar at Mayo Clinic, subject to hospital availability and case acceptance.
Why Consider Dr. S. Vincent Rajkumar?
Dr. Rajkumar combines decades of specialised clinical practice with leadership in global myeloma research, making him one of the most sought-after specialists for multiple myeloma, amyloidosis, and MGUS.
Areas of Specialisation
Focused expertise in multiple myeloma, amyloidosis, MGUS, and plasma cell disorders across diagnosis, risk stratification, clinical trials, and novel therapy development.
Dr. Rajkumar's clinical and research practice is dedicated to plasma cell disorders. His expertise spans the full care pathway — from early MGUS monitoring through to treatment of relapsed and refractory myeloma — informed by decades of translational research and global trial leadership.
Multiple Myeloma
Comprehensive management of newly diagnosed, relapsed, and refractory multiple myeloma including risk stratification and novel therapy selection.
- arrow_rightBiomarker-based diagnosis and disease staging
- arrow_rightRisk stratification using cytogenetics and clinical parameters
- arrow_rightSmouldering myeloma monitoring and intervention planning
- arrow_rightImmunomodulatory drugs including thalidomide, lenalidomide, and pomalidomide
- arrow_rightProteasome inhibitor-based regimens
- arrow_rightMonoclonal antibody therapies for eligible patients
- arrow_rightClinical trial enrolment for eligible patients
Amyloidosis & Monoclonal Gammopathies
Specialist management of amyloidosis, MGUS, and related monoclonal gammopathy conditions.
- arrow_rightDiagnosis and organ assessment in systemic amyloidosis
- arrow_rightTreatment planning for AL amyloidosis
- arrow_rightMultidisciplinary coordination for complex amyloidosis cases
- arrow_rightStructured monitoring programmes for MGUS
- arrow_rightRisk stratification for progression to myeloma or amyloidosis
- arrow_rightEpidemiological assessment including racial disparity considerations
Clinical Research & Biomarker Development
Translational research integrating biomarker science with clinical trial design to advance myeloma treatment outcomes.
- arrow_rightDevelopment and validation of diagnostic biomarkers for myeloma and MGUS
- arrow_rightEpidemiology of monoclonal gammopathies and racial disparities
- arrow_rightPrognostic modelling and clinical outcomes research
Procedures & Clinical Services
Diagnosis, treatment planning, clinical trial participation, and second opinions in multiple myeloma and related plasma cell disorders.
Dr. Rajkumar's clinical services at Mayo Clinic include the full spectrum of myeloma care from initial diagnosis and risk stratification through to treatment of relapsed disease, supported by ongoing participation in clinical trials and research-driven decision-making.
Diagnosis & Risk Stratification
DiagnosisComprehensive evaluation for multiple myeloma, smouldering myeloma, MGUS, and amyloidosis using advanced biomarker and clinical criteria.
Myeloma Treatment Planning
Medical OncologyEvidence-based and research-informed treatment planning for newly diagnosed and relapsed or refractory multiple myeloma.
Clinical Trial Participation
Complex DiseasePrincipal investigator and committee leadership experience across multiple pivotal myeloma trials, including access to novel investigational treatments.
Second Opinion Consultations
Second OpinionSpecialist second opinions for patients with complex myeloma, amyloidosis, or MGUS diagnoses, including review of pathology, imaging, and prior treatment.
Long-Term Monitoring
MonitoringStructured monitoring for MGUS and smouldering myeloma patients, with evidence-based protocols for assessing progression risk.
Research & Publications
Over 800 peer-reviewed publications and global leadership in myeloma clinical research.
Dr. Rajkumar is one of the most published researchers in multiple myeloma and plasma cell disorders globally. His work spans biomarker development, novel therapies, epidemiology, prognosis, clinical trial design, and racial disparities. He serves as Editor-in-Chief of Blood Cancer Journal.
Dr. Rajkumar's full publication list is available via Mayo Clinic's faculty profile and Google Scholar. A more detailed bibliography may be requested through Mayo Clinic directly.
Education & Training
Dr. Rajkumar completed his medical training in India before pursuing specialty residency and fellowship training in the United States, culminating in ABIM Hematology certification and a distinguished academic career at Mayo Clinic.
Clinical Experience
Dr. Rajkumar has spent his entire specialist career at Mayo Clinic, Rochester, rising to Professor of Medicine and assuming multiple national and international leadership roles in myeloma research and clinical trial governance.
Languages & International
Dr. Rajkumar consults in the following language.
CancerFax can coordinate professional medical interpreter support for international patients consulting with Mayo Clinic specialists.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. S. Vincent Rajkumar
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. S. Vincent Rajkumar's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. S. Vincent Rajkumar's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. S. Vincent Rajkumar before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. S. Vincent Rajkumar's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. S. Vincent Rajkumar's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. S. Vincent Rajkumar's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. S. Vincent Rajkumar
Dr. S. Vincent Rajkumar specialises in multiple myeloma, amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma, and related plasma cell disorders. These are confirmed areas of clinical and research focus listed on his Mayo Clinic profile.
Dr. Rajkumar is a Professor of Medicine and consultant at Mayo Clinic, Rochester, Minnesota, United States — one of the world's leading academic medical centres for haematology and oncology.
Dr. Rajkumar practises at Mayo Clinic, Rochester, which has established international patient services. CancerFax can assist with coordinating medical-report submission and consultation support for international patients, subject to Mayo Clinic's availability and case acceptance criteria.
You can submit your medical reports through CancerFax. The CancerFax team will review your documents, prepare the case for submission, and coordinate the next steps with the hospital, subject to Dr. Rajkumar's availability. Second-opinion requests typically require pathology reports, imaging, treatment history, and relevant laboratory results.
Yes. Dr. Rajkumar has served as principal investigator on multiple pivotal clinical trials for multiple myeloma, including studies that contributed to the US FDA approval of thalidomide for myeloma treatment. He chairs the Myeloma Committee of the ECOG-ACRIN Cancer Research Group and co-chairs the International Myeloma Working Group. Eligibility for active trials would need to be confirmed directly with Mayo Clinic at the time of consultation.
Dr. Rajkumar has more than 800 publications, including peer-reviewed research papers, reviews, book chapters, and editorials. The International Myeloma Foundation notes that his output includes over 500 original research papers and more than 200 reviews and book chapters. He serves as Editor-in-Chief of Blood Cancer Journal.
Connect with S. Vincent Rajkumar Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.